SCHEMBL7837239

SCHEMBL7837239

Nc1ccc(S(=O)(=O)Nc2cccc3[nH]ccc23)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 4/20 1.00
CA1 P00915 5/20 0.51
CA2 P00918 5/20 0.51
CA9 Q16790 4/20 0.51
KMT2A Q03164 3/20 0.49
MEN1 O00255 2/20 0.49
TDP1 Q9NUW8 1/20 0.49
MAPK1 P28482 1/20 0.46
AURKA O14965 1/20 0.44
DHFR P00374 1/20 0.44
LMNA P02545 1/20 0.44
TSHR P16473 1/20 0.44
RECQL P46063 1/20 0.44
CA12 O43570 1/20 0.44
CA3 P07451 1/20 0.44
CA6 P23280 1/20 0.44
CA5A P35218 1/20 0.44
CA7 P43166 1/20 0.44
CRBN Q96SW2 1/20 0.44
CA14 Q9ULX7 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5746400 0.87 HTR6 (0.76) HTR6KMT2AMEN1TDP1MAPK1
SCHEMBL8414789 0.83 HTR6 (0.71) HTR6CA1CA2CA9KMT2A
SCHEMBL1635040 0.80 HTR6 (1.00) HTR6CA1CA2CA9KMT2A
SCHEMBL7836637 0.79 GAA (0.68) HTR6KMT2AMEN1TDP1LMNA
SCHEMBL2844017 0.79 HTR6 (0.65) HTR6CA1CA2CA9MAPK1
SCHEMBL164503 0.76 RECQL (0.76) HTR6CA1CA2CA9KMT2A
SCHEMBL27438507 0.75 HTR6 (0.60) HTR6MAPK1KEAP1HTT
SCHEMBL30955295 0.75 HTR6 (0.60) HTR6MAPK1KEAP1HTT
SCHEMBL25284230 0.74 HTR6 (0.58) HTR6TDP1LMNAALDH1A1MAPT
SCHEMBL10374550 0.73 HTR6 (0.57) HTR6KMT2AMEN1MAPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0815861-B1 Sulphonamides and their use HOFFMANN LA ROCHE (CH) 2001-09-19 EP claimed
EP-0815861-A1 Sulphonamides and their use F. HOFFMANN-LA ROCHE AG (CH) 1998-01-07 EP claimed
EP-0815861-B1 Sulphonamides and their use HOFFMANN LA ROCHE (CH) 2001-09-19 EP disclosed
US-6030976-A SELECTIVE AFFINITY TO 5HT-6 RECEPTORS; CENTRAL NERVOUS SYSTEM DISORDERS; ALZHEIMER'S DISEASE, PSYCHOSES, SCHIZOPHRENIA, MANIC DEPRESSIONS, MEMORY DISORDERS, PARKINSON'S DISEASE, AMYOTROPHIC LATERAL SCLEROSIS AND HUNTINGTON'S DISEASE HOFFMAN-LA ROCHE INC. (US) 2000-02-29 US disclosed
US-5998665-A THERAPY FOR NERVOUS SYSTEM DISORDERS HOFFMANN-LA ROCHE INC. (US) 1999-12-07 US disclosed
US-5939451-A INDOL-4-YL-BENZENESULFONAMIDES AS ACTIVE MATERIAL TREATING MALARIA, BACTERIAL INFECTION, NEUROLOGICAL DISORDERS HOFFMANN-LA ROCHE INC. (US) 1999-08-17 US disclosed
US-5932599-A 4-AMINO-N-(PYRIDINYL-4-YL)-BENZENESULFONAMIDES AS ACTIVE MATERIAL TREATING MALARIA, BACTERIAL INFECTION, NEUROLOGICAL DISORDERS HOFFMANN-LA ROCHE INC. (US) 1999-08-03 US disclosed
EP-0815861-A1 Sulphonamides and their use F. HOFFMANN-LA ROCHE AG (CH) 1998-01-07 EP disclosed